The size of the mammography market in Europe was valued at USD 458.41 million in 2022. This value is expected to reach USD 606.83 million by the end of 2027, with a CAGR of 5.77% during the forecast period.
In the review period, Breast cancer is the most prominent disease-causing death among women worldwide. Mammography devices aids in the detention of breast cancer in early stages. The increasing mortality rate has risen the need for diagnosing breast cancer patients leading to increasing demand for mammography devices.
Mammography is a standard diagnostic and screening technique for screening the breast tissues for any malignant tissues. The testing is done through low dose X-rays to get detailed imaging of the inside of the breast. Screening mammography involves random checking among women for breast cancer without any signs of the disease. Whereas, diagnostic mammography is undertaken if there are any symptoms of the disease and can also be used in evaluating the results of the screening mammogram.
The mammography market's driving factors include rising prevalence of cancer, technological innovations in breast imaging, increasing aging population, and rising awareness among individuals propelling early breast screening. However, the market is hampered by the enormous costs associated with the expensive imaging, stringent regulatory bodies, and side effects associated with these devices.
This research report segmented and sub-segmented the Europe Mammography Market into the following categories:
The European Mammography market is the second leading region in the global market. Growing incidences of chronic diseases, advancement in technology, and emerging research facilities in this region are majorly driving the market growth.
Among different nations of Europe, Germany is one of the fastest-growing markets due to the gigantic productive economy, adoption of advanced technology, and rising incidences of breast cancer are majorly driving the German mammography market. In 2018, around 72,000 new cases of breast cancer were recorded in which 19,000 women were dead.
However, the United Kingdom's mammography market is estimated to record the highest growth rate during the forecast period. Breast cancer is the fourth most leading cause of cancer deaths in the UK and registered 7% of cancer deaths in 2017. From 2015 to 2017, an average of 31 women was passed away due to breast cancer. This rising prevalence and incidence of breast cancer in the United Kingdom is estimated to offer significant growth to the UK mammography market.
Some of the prominent companies leading the Europe Mammography Market Profiled in the Report are include Fujifilm, GE Healthcare, Hologic, Metaltronica, Philips Healthcare, Planmed, Siemens Healthcare, Sonocine, and Toshiba Medical Systems.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: email@example.com